OR WAIT 15 SECS
ICYMI, some of the content featured this week includes a new episode of The Cutaneous Connection, how to eat for healthy skin, botulinum toxin as a potential treatment for scars, fat grafting, plus more.
In case you missed it, this week we released a new episode of our podcast, The Cutaneous Connection, which takes a look at a recent International Society of Dermatology survey asking about climate change and its effect on skin diseases. Also, we featured articles about fat grafting, botulinum toxin as a potential treatment for scars, U.S. Food and Drug Administration approval of a new plaque psoriasis topical, how to eat for healthy skin, plus more.
This episode discusses a recent survey conducted by the International Society of Dermatology’s Climate Change Committee involving climate change and its effect on skin diseases throughout the world with one of its committee members, Sarah Coates, M.D.
This month, Todd Petersen, CEO of VitalSkin Dermatology, focuses on how to identify potential buyers and perform your own initial due diligence on them before putting your practice up for sale.
This week’s edition of The Mainstream Patient features stories about the difference between physical and chemical sunscreen, everything you need to know about exfoliants, a complete guide to laser hair removal, plus more.
Dr. Joe acquired a new laser prior to the pandemic. Three patients are scheduled for treatment during which he had told them a laser expert would be present. The laser expert deferred due to COVID-19. After carrying out the procedures alone, one patient sues for battery, though there were no adverse events. Is this battery? Can Dr. Joe use COVID-19 challenges as a defense?
A recent study aimed to elucidate the association between variations in the skin’s microbiome and the development of rosacea symptoms.
Hema Sundaram, M.A., M.D., FAAD, breaks down how botulinum toxin can be used to treat scars, a topic she discussed during her presentation at the AAD Virtual Meeting Experience (VMX) on June 12.
Special skin mineral supplementation is not necessary as long as patients make educated dietary choices.
In this video, Hema Sundaram, M.A., M.D., FAAD, shares pearls on fat grafting from her presentation at the AAD Virtual Meeting Experience (VMX) in June.
DMK Skin Care launches new products at their U.S. DMK clinics to help combat the effects of summer on the skin.
Botulinum toxin may help address erythema and flushing in patients with refractory rosacea, according to data presented by Hema Sundaram, M.A., M.D., FAAD, at the AAD Virtual Meeting Experience (VMX) on June 12.
Studies offer further insight into risks associated with biologic therapy. One study suggests it’s not necessary to stop biologic therapy preoperatively to limit post-operative infections. Another systematic review does not rule out melanoma risk.
In this video, Hema Sundaram, M.A., M.D., FAAD, highlights important safety considerations to keep in mind regarding laser-assisted drug delivery.
The U.S. Food and Drug Administration has approved Wynzora Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%, MC2 Therapeutics) for adult with plaque psoriasis. Wynzora is equipped with the MC2 Therapeutics’ patented PAD Technology and is currently under review in the EU.
Bakuchiol offers patients the skin renewal benefits of retinol without the irritation, redness, peeling and sun-sensitivity.